Stock LQDA LIQUIDIA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Liquidia Corporation

Equities

LQDA

US53635D2027

Market Closed - Nasdaq
Other stock markets
 21:00:00 08/05/2024 BST 		5-day change 1st Jan Change
12.5 USD -2.65% Intraday chart for Liquidia Corporation -5.09% +3.91%
04-01 Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension MT
04-01 Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
AQ
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
GL
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
AQ
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
GL
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
AQ
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
GL
Liquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
GL
Liquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
GL
Spotlight On Upcoming Oral Arguments – February 2024
AQ
Liquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
GL
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA inhalation powder
AQ
Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
GL
Liquidia Corporation Announces Updates to Operations Leadership
GL
Liquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
GL
Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
GL
Liquidia Corporation Announces $100 Million in New Financings
GL
Federal Circuit Evaluates Impact Of The Final Written Decision (FWD) In A Parallel Inter-Partes Review (IPR) On District Court's Decision Of Invalidity And Infringement
AQ
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
GL
U.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LQDA Stock
  4. News Liquidia Corporation
  5. Press Releases